Key result
Extended biventricular assist device support for 12 months in a patient with giant cell myocarditis led to resolution of active disease at the time of heart transplantation.
Population
1 Asian woman with giant cell myocarditis presenting with palpitations and syncope, with rapidly…
Design
Case_report
Follow-up
12 months
Authors
Loading...
Hypothesis-generating for prolonged BiVAD support in giant cell myocarditis; prospective studies needed before clinical adoption.
Case Report (n=1)
Extended biventricular assist device support without immunosuppression may allow for the resolution of active giant cell myocarditis prior to heart transplantation.
Eid et al. (2009) conducted a case report in Giant cell myocarditis (n=1). Biventricular assist device (BiVAD) was evaluated on Resolution of active giant cell myocarditis. Extended biventricular assist device support for 12 months in a patient with giant cell myocarditis led to resolution of active disease at the time of heart transplantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: